


Vinjec IV Injection 1g — Vancomycin Hydrochloride for Serious Bacterial Infections
Pay in 3 Installments of
Rs.
754
Description
Vinjec IV Injection 1g — Vancomycin Hydrochloride
Vinjec IV Injection 1g is a hospital-grade glycopeptide antibiotic containing Vancomycin Hydrochloride, indicated for serious and life-threatening infections caused by susceptible Gram-positive organisms, including Methicillin-resistant Staphylococcus aureus (MRSA). It works by inhibiting bacterial cell-wall biosynthesis and is bactericidal against most Gram-positive pathogens.
Vinjec IV is prescribed for staphylococcal endocarditis, septicemia, osteomyelitis, lower respiratory tract infections, and skin and soft tissue infections. It is reserved for patients with penicillin hypersensitivity or infections caused by organisms resistant to other antibiotics.
Clinical Administration & Monitoring
- Administered exclusively via slow intravenous infusion (minimum 60 minutes) to prevent infusion-related reactions
- Renal function (serum creatinine, BUN) must be monitored throughout therapy
- Therapeutic drug monitoring (TDM) of vancomycin serum levels is required, especially in high-risk patients
- Audiological monitoring recommended during prolonged courses due to ototoxicity risk
- Dose adjustment required in patients with renal impairment
This is a prescription-only medicine. It is available through hospital-grade injections and general medicines at Derma.pk. For prescription submission, send to sales@derma.pk or WhatsApp +92-320-5999650.
Usage & Benefits
- Effective against MRSA and other methicillin-resistant Staphylococcus aureus strains
- Treats serious infections including staphylococcal endocarditis, septicemia, and osteomyelitis
- Alternative for patients with penicillin hypersensitivity or beta-lactam-resistant infections
- Bactericidal mechanism disrupts cell-wall synthesis for reliable elimination of Gram-positive pathogens
- Intravenous formulation provides rapid systemic therapeutic levels in critical care settings
How To Use
- Administered exclusively by qualified healthcare professionals in a hospital or clinical setting
- Infuse intravenously over a minimum of 60 minutes to prevent infusion-related reactions (Red Man Syndrome, hypotension)
- Dose determined by indication, body weight, and renal function — consult prescribing physician
- Monitor serum vancomycin trough/AUC levels throughout therapy (TDM)
- Check renal function (serum creatinine, BUN) and audiological status during prolonged treatment
FAQs
What is Vinjec IV Injection used for?
Vinjec IV Injection 1g is a glycopeptide antibiotic used in hospital settings to treat serious Gram-positive bacterial infections including MRSA, staphylococcal endocarditis, septicemia, osteomyelitis, and lower respiratory tract infections.
Why must vancomycin be infused slowly?
Rapid infusion can cause Red Man Syndrome (flushing, hypotension, erythema) and in rare cases cardiac arrest. Infusion over at least 60 minutes minimises these risks.
What monitoring is required during vancomycin therapy?
Renal function tests (creatinine, BUN), therapeutic drug monitoring (TDM) of serum vancomycin levels, and audiological assessment during prolonged courses are standard clinical requirements.
